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Abstract: Designing scaffolds made from natural polymers may be highly attractive for tissue
engineering strategies. We sought to produce and characterize chitosan-coated collagen membranes
and to assess their efﬁcacy in promoting chondrocyte adhesion, growth, and cytokine secretion.
Porous collagen membranes were placed in chitosan solutions then crosslinked with glutaraldehyde
vapor. Fourier transform infrared (FTIR) analyses showed elevated absorption at 1655 cm´1 of
the carbon–nitrogen (N=C) bonds formed by the reaction between the (NH2) of the chitosan and
the (C=O) of the glutaraldehyde. A signiﬁcant peak in the amide II region revealed a signiﬁcant
deacetylation of the chitosan. Scanning electron microscopy (SEM) images of the chitosan-coated
membranes exhibited surface variations, with pore size ranging from 20 to 50 μm. X-ray
photoelectron spectroscopy (XPS) revealed a decreased C–C groups and an increased C–N/C–O
groups due to the reaction between the carbon from the collagen and the NH2 from the chitosan.
Increased rigidity of these membranes was also observed when comparing the chitosan-coated and
uncoated membranes at dried conditions. However, under wet conditions, the chitosan coated
collagen membranes showed lower rigidity as compared to dried conditions. Of great interest, the
glutaraldehyde-crosslinked chitosan-coated collagen membranes promoted chondrocyte adhesion,
growth, and interleukin (IL)-6 secretion. Overall results conﬁrm the feasibility of using designed
chitosan-coated collagen membranes in future applications, such as cartilage repair.
Keywords: chitosan; collagen; membrane; chondrocytes; interleukin (IL)-6
1. Introduction
Cartilage damage is common among the general population and is more often anticipated
in young and physically active people. The causes of lesions of the articular cartilage are many,
including traumatic damage, osteoarthritis (OA), and osteochondritis dissecans, to name only the
most frequently reported knee injuries [1,2]. OA, a multi-faceted disease, is characterized by
functional disability, stiffness, and limitations with regard to physical activity [3,4]. The widespread
prevalence of this disease has led to signiﬁcant economic and social burdens [3,4]. To improve patient
health and well-being, restoring damaged cartilage tissue back to a functionally normal state has
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been a major challenge for orthopedic surgeons. For OA, joint replacement remains the ultimate
treatment [5]. Other initiatives using intra-articular hyaluronic acid constitute a viable treatment for
patients with early knee OA [6]. Various other treatment possibilities are available to treat damaged
cartilage, including bone marrow stimulation techniques such as abrasion arthroplasty [7]. In this
study, it was concluded that arthroscopic abrasion arthroplasty was a valid treatment for femoral
condylar full-thickness defects of the knee, even long term, particularly for younger patients and
those with smaller lesions [7]. Autologous chondral transplantation has also produced encouraging
results [8]. Early and intermediate-term outcomes have been reported to be positive, yet variable
over longer periods of time [8,9]. One major disadvantage of the autologous chondral transplant
technique is the need for a donor site, which leads to additional morbidity [9]. To overcome the
limitations of the autologous technique, chondral allogeneic transplantation has been proposed as an
alternative strategy to resurface large cartilage defects, with good clinical outcomes [10]. However,
chondral allogeneic grafting requires donor-recipient size matching, testing for infectious diseases,
and implantation within a short time frame to ensure chondrocyte viability [11,12]. The search thus
continues for a useful initiative to treat cartilage damage for improved patient well-being. This may
involve tissue engineering approaches designed to restore adequately pathologically altered tissue
structures through the implantation of cell-populated supportive scaffolds [13].
Scaffold-based tissue engineering, one of the most studied approaches to regenerate different
types of tissues, involves seeding cells on a porous biodegradable matrix [14]. Natural
biological materials, such as collagen and ﬁbrin, are promising candidate scaffolds for cartilage
engineering [15,16] as they play multiple key roles in structural maintenance of the defect shape
and void volume for vascularization, and serve as temporary extracellular matrix for cell adhesion,
proliferation, differentiation, and maturation [17,18]. Collagen scaffolds have been actively used in
research as well as in clinical applications for meniscus and osteochondral defect regeneration [19].
The most widely used collagen in biomedical applications is collagen type I that provides a
welcoming microenvironment for chondrocytes to produce extracellular matrix [20,21]. Chitosan is
also being widely investigated as a natural biomaterial for many biomedical applications due not
only to its biocompatibility, biodegradability, antimicrobial properties, and functionality [22], but
also its effective mechanical stability and a good ﬁlm-forming capacity which makes it useful for the
development of chitosan-coated ﬁlms [23,24]. The blends of collagen and biodegradable polymers,
such as polylactide or polycaprolactone, are often used as cell culture substrates to generate in vitro
tissues for potential clinical applications [25,26]. Such studies suggest the use of chitosan-collagen
hybrid membranes for cartilage tissue regeneration. The objectives of our study were thus to design
and characterize chitosan-coated collagen membranes and to investigate chondrocyte adhesion,
growth, and cytokine secretion following cell interaction with these designed membranes.
2. Materials and Methods
2.1. Materials
Chitosan powder with a deacetylation degree of ě75% was purchased from Sigma-Aldrich
Canada Co. (Oakville, ON, Canada). The CollaTape absorbable collagen membrane was obtained
from Zimmer Dental Inc. (Carlsbad, CA, USA). The CollaTape is a biocompatible three-dimentional
porous soft collagen sponge easy to handle with good mechanical properties. It is already approved
for human use basically in dental surgery, but also as a scaffold for in vitro [27] and in vivo tissue
engineering [28]. Because of the coherent sponge structure and composition, its use in this study will
be of great interest in engineering a chitosan-collagen composite scaffold.
The glacial acetic acid was obtained from EMD Chemicals Inc. (Gibbstown, NJ, USA), and the
glutaraldehyde was also procured from Sigma-Aldrich. Chondrocyte cells (HTB-94 cells, a human
chondrosarcoma cell line with chondrogenic properties) were purchased from ATCC Cell Biology
(Manassas, VA, USA).
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2.2. Engineering of Chitosan-Coated Collagen Membranes
Chitosan powder (0.1 wt %, 1 wt %) was dissolved in 1% acetic acid under stirring (2000 rpm)
with an electromagnetic bar to obtain a homogenous mixture. The chitosan solutions were then
used to coat the CollaTape absorbable collagen membranes (10 mm diameter). Contact between
the chitosan and the collagen membranes was maintained for 18 h at room temperature without
any pressure to enable the chitosan to penetrate into the pores of the collagen membranes. The
chitosan-coated collagen membranes were dried for 24 h at room temperature. The mats were then
collected, washed or not with distilled water 3 ˆ 30 min, and placed or not in a vapor chamber and
subsequently exposed to glutaraldehyde (12.5%, Sigma-Aldrich, St. Louis, MO, USA) vapor for 18 h,
after which time the membranes were rewashed 3 ˆ 30 min with distilled water and subsequently
subjected to chemical characterizations.
2.3. Material Characterization
2.3.1. Fourier Transform Infrared (FTIR) Characterization
Chitosan-coated and non-coated collagen membranes were subjected to FTIR analyses with a
Nicolet Magna 550 FTIR (Thermo-Nicolet, Madison, WI, USA) equipped with a germanium-coated
KBr beamsplitter and a deuterated triglycine sulphate (DTGS)/KBr detector. Spectra were recorded
in ATR mode using a Split Pea (Harrick Corp., Ossining, NY, USA) featuring a 200-μm Si internal
reﬂection element. One hundred ﬁfty scans were recorded at a resolution of 4 cm´1 and OMNIC
(Thermo-Nicolet Co.) software was used for data acquisition and spectra processing (n = 4).
2.3.2. Scanning Electron Microscopy (SEM) Characterization
Chitosan-coated (0.1% and 1%) and non-coated collagen membranes were subjected to SEM
analyses. For this purpose, membrane dehydration was performed in a series of ethanol solutions
of increasing concentrations (50, 70, 90, and twice at 100%), with a 5-min dehydration treatment in
each solution. The dehydrated specimens were kept overnight in a vacuum oven at 25 ˝C, after which
time they were sputter-coated with gold and examined under a JEOL 6360 LV SEM (Soquelec Ltd.,
Montréal, QC, Canada) at an accelerating voltage of 30 kV. Photos were taken from the membrane
surface and on membrane cross-sections. Analyzing the membrane structure using cross-sections
will help to evaluate the presence of internal pores and their interconnectivity inside the designed
chitosan-coated collagen membranes (n = 4).
2.3.3. X-ray Photoelectron Spectroscopy (XPS) Characterization
The surface chemical elements of the collagen membranes, as well as the 0.1% and 1%
chitosan-coated collagen membranes were analyzed with a PerkinElmer PHI 5600 XPS System (XPS,
Perkin-Elmer, Eden Prairie, MN, USA) using a standard magnesium X-ray source (1253.6 eV). Emitted
photoelectrons were detected at a 45˝ take-off angle and analyzed with a hemispheric electron energy
analyzer operated at pass energy of 187.9 eV for the survey scans and 5.85 eV for the high-resolution
scan. For each membrane, three locations of 0.8 ˆ 0.8 mm2 were analyzed and averaged. The vacuum
in each sample chamber was maintained at 10´10 torr during the analysis of the surface chemistry
of each specimen. All of the measurements were taken on the air-exposed side of the membranes
during membrane preparation. Curve ﬁtting to the high-resolution spectrum was decomposed using
a Gaussian (90%)/Lorentzian (10%) curve-ﬁtting program (n = 4).
2.3.4. Mechanical Properties and Tensile Strength Characterization
Following their production, chitosan-coated and non-coated collagen membranes were
crosslinked with glutaraldehyde, washed extensively with phosphate buffered saline (PBS), dried
for 48 h, and then subjected to mechanical analyses. With a second set of membranes, we tested the
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wet condition on the mechanical properties. This was performed by incubating the membranes for
24 h under humid condition referring to a closed chamber containing water rich absorbent papers,
at room temperature. For all membranes, mechanical (tensile) property assessments were performed
at 25 ˝C and 50% relative humidity using RSA-3 DMA (from TA Instruments, New Castle, DE, USA)
equipped with ﬁlm tensile clamping system and a load cell of 35 N. The tensile tests were done
at a constant cross-head speed of 1 mm/min. Tensile modulus was determined in the most linear
region of the stress/strain curve using the secant method. Four rectangular membrane samples of
10 mmˆ 10 mm in size were analyzed per condition (n = 4). Sample thickness was around 0.2 mm for
non-coated collagen membranes and around 0.4 mm for chitosan-coated membranes.
2.3.5. Evaluate Potential Degradation of the Membranes
The experiments were performed in culture medium at 37 ˝C. Samples of 0.5 cm diameter
from each designed membrane were weighed (initial weight), placed in wells of a 24-well plate and
submerged in 2 mL of culture medium for different period of time (48 and 96 h). At the end of
each incubation period, the samples were removed from the culture medium and placed between
absorbent papers to remove as much as possible the medium. They were then dried for 4 days under
sterile conditions (in tissue culture hood) and weighed (ﬁnal weight) (n = 5).
2.4. Chondrocyte Culture on Chitosan-Coated Collagen Membranes
Human chondrosarcoma cell line HTB-94 was cultured in Dulbecco’s Modiﬁed Eagle’s-F12
(DMEF) medium supplemented with transferrin at 14.3%, 10 μg/mL of human epidermal growth
factor (EGF) (Chiron Corp., Emeryville, CA, USA), 0.2 mg/mL of hydrocortisone (Calbiochem,
La Jolla, CA, USA), 5 mg/mL of bovine insulin, 250 μg/mL of fungizone, 2 ˆ 10´9 M of
3,31,51-triiodo-L-thyronine, 31 g/L of penicillin, 50 g/L of streptomycin, and 5% fetal calf serum
(NCS, fetal clone II; Hyclone, Logan, UT, USA). When the culture reached 80% conﬂuence, cells
were detached from the culture ﬂasks by trypsin treatment and were counted, and the concentration
was adjusted to 106 cells/mL of DMEF complete medium for subsequent experiments. Prior to cell
seeding, chitosan-coated (0.1% or 1%) and non-coated-collagen membranes were ﬁrst introduced into
a low-adherence 12-well plate at one membrane per well, then pre-incubated for 3 h in DMEF at
37 ˝C in a 5% CO2 humid atmosphere to prepare the membrane receiving the cells. At the end of the
pre-incubation period, the culture medium was discarded and each membrane was overlayed with
chondrocytes at a density of 105 cells/membrane in 50 μL of DMEF medium. Cells were allowed
to adhere for 120 min, after which time 2 mL of complete DMEF were added to each well. The cells
were then incubated at 37 ˝C in a CO2 humid atmosphere for various culture periods prior to analysis
(n = 4).
2.4.1. Cell Adhesion as Determined by Hoechst Staining
Following cell seeding at 105 cells/membrane and culture for 24 h, chitosan-coated and
non-coated collagen membranes were subjected to Hoechst staining. Brieﬂy, the samples were ﬁrst
ﬁxed with methanol/glacial acetic acid (75/25) for 3 ˆ 2 min, then washed 3 times with PBS. After
that, they were incubated with Hoechst 33342 (H42) (Riedel de Haen, Seele, Germany) (1 μg/mL) in
PBS for 15 min at room temperature in a dark atmosphere. Following three washes with deionized
water, the samples were observed under an epiﬂuorescence light microscope (Axiophot, Zeiss,
Oberkochen, Germany) and photographed using a high-resolution digital camera. Representative
photos were reported (n = 4).
2.4.2. Investigation of Cell Proliferation by Mean of MTT Assay
Chondrocytes were seeded at 105 cells/membrane and cultured in a CO2 humid atmosphere at
37 ˝C for either 48 or 96 h. Following each culture period, chondrocyte proliferation was assessed
using the 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma, St. Louis,
7676
Materials 2015, 8, 7673–7689
MO, USA) staining assay, which measures cell growth as a function of mitochondrial activity. MTT
assay is based on the hydrolysis of the tetrazolium ring by mitochondrial dehydrogenase, resulting
in an insoluble blue reaction product (formazan). Brieﬂy, a stock solution (5 mg/mL) of MTT was
prepared in PBS and added to each culture well at a ﬁnal concentration of 1% (v/v). The chondrocyte
cultures were then incubated for 4 h at 37 ˝C with the MTT, after which time the supernatant was
removed, and the adherent cells were washed twice with warm culture medium. Following the ﬁnal
wash, 2 ml of a solution containing hydrochloric acid at (0.04 N) and isopropanol were added to each
culture well, with the incubation extended for another 15 min. At this step, 200 μL (in triplicate) of
the reaction mixture was transferred to a 96-well ﬂat-bottom plate where absorbance (optical density,
OD) was measured at 550 nm by means of a microplate reader (Model 680, Bio-Rad Laboratories inc,
Hercules, CA, USA). Results were reported as the means ˘ standard deviation (SD) (n = 6).
2.4.3. Evaluation of the Number of Live Cells after Culture on Chitosan-Coated Collagen
Membranes
We seeded chondrocytes onto each membrane and cultured them for 48 or 96 h. At the
end of each culture period, we detached the cells from each membrane with 0.05% trypsin-0.1%
ethylene-diaminetetraacetic acid (EDTA). Collected cells were washed twice with culture medium.
The pellet was re-suspended in 1 mL of 10% fetal calf serum supplemented culture medium then
used to determine cell viability using the Trypan blue exclusion test [29]. For this purpose, 20 μL
of each cell suspension was mixed with the same volume of Trypan blue solution. This step was
performed three times for each cell suspension. The cells mixed with trypan blue were incubated in
ice for 5 min. Then the total numbers of live cells (trypan bleu exclusion), and dead cells (trypan bleu
inclusion) were determined. The results were reported as means ˘ SD of live cells (n = 3).
2.4.4. Interleuk-6 Quantiﬁcation Following Chondrocyte Culture on Chitosan-Coated Collagen
Membranes
HTB-94 chondrocytes were seeded on collagen membranes or chitosan-coated collagen
membranes and cultured for 48 or 96 h. The supernatant from each condition was then collected
and used to determine interleukin (IL)-6 levels. IL-6 ELISA kits were purchased from R&D Systems
(Minneapolis, MN, USA). Brieﬂy, the supernatants were ﬁrst collected in tubes containing 1.0 μL of
a protease inhibitor cocktail (Sigma-Aldrich), immediately ﬁltered through 0.22-μm ﬁlters, and used
thereafter to measure IL-6 levels by ELISA assay. Mediator levels were read at 450 nm by mean of
a microplate reader (Model 680, Bio-Rad). The minimum detectable concentrations for IL-6 were
lower than 0.7 pg/mL, as reported by the manufacturer. Each experiment was repeated four times
and the means ˘ SD were calculated and presented as the levels of cytokine per mg of total protein
extracted from the same cell cultures. Indeed, following supernatant collection, the adherent cells
were ﬁrst detached from the culture plate using trypsin and then centrifuged for 10 min at 1200 rpm,
after which time the pellet was re-suspended in 300 μL of cell lysis buffer (Cell Signaling Technology,
Inc., Danvers, MA, USA), incubated 5 min at 4 ˝C, and subsequently spun out for 10 min in a cold
microfuge. The collected supernatant was used to determine the total protein concentration using the
Bradford assay [30].
3. Statistical Analyses
Each experiment was performed at least three times. The experimental values are given as
mean ˘ SD. The statistical signiﬁcance of the differences between the control and test values was
evaluated using a one-way analysis of variance (ANOVA, STAT 200). Results were considered
signiﬁcant when p < 0.05 and the values of the collagen membranes and chitosan-coated collagen
membranes were compared. Data were analyzed using the SigmaPlot 2002 software (2004 Systat
Software, Inc., Chicago, IL, USA).
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4. Results and Discussion
Tissue engineering and regenerative medicine have been providing exciting technologies for
the development of functional substitutes aimed to repair and regenerate damaged tissues and
organs [31]. Tissue engineering involves scaffolds combined with cells and suitable biochemical
signals, which promote the design of new organs and tissues. Different materials including natural
and synthetic polymers have been exploited for composite scaffold designing and processing,
attending to diverse needs in tissue engineering and regenerative medicine [32]. Special interest has
been given to the composite biopolymers involving natural and synthetic, but also those combining
natural polymers seeking for biomaterial composites with optimized properties. Natural composite
scaffolds are usually preferred for clinical application because they can easily promote cellular
adhesion, growth and tissue regeneration such as in cartilage repair [33]. It is very advantageous
to use natural biomaterials such as collagen and chitosan as a scaffold material in tissue engineering;
they are bioactive, biocompatible, and they can allow designing composite membranes that possess
mechanical properties similar to those of soft tissues [34,35]. Although it was designed for the
dental application, the CollaTape matrix was previously used to design 3-dimensional (3-D) tissue
for in vitro [28] and in vivo applications [29]. Due to its porosity and biocompatibility, this collagen
sponge offers good conditions for different cell types to adhere, grow and form 3-D tissue. We took
advantage from the CollaTape sponge and engineered composite chitosan-collagen membranes and
characterized by mean of FTIR, XPS and SEM.
The infrared spectrum characterizing the sensitive absorption bands of collagen and chitosan
were located in the amide I, amide II, and amide III regions [36,37]. Comparative FTIR spectra
of the various chitosan-coated collagen membranes engineered in our laboratory are reported in
Figure 1 which shows a strong adsorption at 3300 cm´1 assigned to amide-A (N–H stretching),
as well as a relatively weak adsorption peak at 2950 cm´1 referring to amide-B (C–H stretching).
Three bands recognized as amide I (C=O stretching), amide II (N–H plane deformation), and amide
III are, respectively, located at 1640, 1534 and 1240 cm´1. The chitosan-speciﬁc bands located at
1026 cm´1 (stretching of C–O) and 1084 cm´1 (of OH) were higher on the collagen membranes
coated with 1% chitosan; this increased peak intensity was due to the higher percentage of chitosan
incorporated. The decreased OH peak on the washed collagen membranes coated with 1% chitosan
was due to the reaction between the OH of the chitosan and (H2O). An increased absorption at
1655 cm´1 was observed on the membranes crosslinked with glutaraldehyde due to N=C imine
bonds formed by the reaction between the NH2 of the chitosan and the C=O of the glutaraldehyde.
The absence of adsorption at 1480 cm´1 (C=O of COCH3) and the signiﬁcant peak in the amide II
region revealed elevated deacetylation of the chitosan used in the experiment. When comparing the
neat collagen membranes and those coated with chitosan and crosslinked with glutaraldehyde, the
amide absorption bands remained unchanged. These data are in agreement with previously reported
work [38,39].
Mechanical properties are crucial when designing a scaffold for use in tissue engineering,
as the scaffold must display suitable characteristics to facilitate in vitro handling and withstand
in vivo environments [40–42]. Although it is particularly attractive in tissue engineering due to its
excellent biocompatibility, the relatively weak mechanical properties of collagen may limit its use as
a scaffold [40,41]. Chitosan, on the other hand, shows interesting biological potential as a scaffold,
but exhibits low mechanical properties and poor thermal and chemical stability [38,39]. To get a
useful composite membrane containing only natural polymers, collagen and chitosan can therefore
be crosslinked to improve their mechanical properties [43,44]. To consolidate chitosan-coated
collagen membranes, we exposed them to glutaraldehyde vapor for 24 h then washed them
6 ˆ 30 min with distilled water or culture medium. We observed that these membranes showed
no visible signs of degradation. It is important to note that the use of glutaraldehyde vapor
is better than impregnating the membrane in the glutaraldehyde solution. Indeed, our analyses
demonstrated that, if immersed even for 6 h in the glutaraldehyde solution, the membrane adopts
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a solid structure that is easy to break (data not shown). Thus, glutaraldehyde vapor treatment
is the appropriate way to crosslink chitosan to collagen getting a good composite membrane.
Glutaraldehyde is a well-known cross-linker that has been utilized extensively [45]. Recently, it has
been demonstrated that glutaraldehyde vapor phase cross-linking produced stiffest films with higher
ultimate tensile strength as compared to glutaraldehyde solution [46]. These are supportive to the
data we are presenting in this study; such data allowed us to perform the subsequent experiments
using glutaraldehyde cross-linked chitosan-coated collagen membranes. Designed membranes were
subjected to ultrastructural analyses by mean of SEM. As shown in Figure 2 the chitosan-coated
and non-coated collagen membranes exhibited surface variations in terms of pore size and pore
distribution. In the non-coated membrane, a significant number of pores were observed, with a
large pore size ranging from 30 to 100 µm. The number of pores and their size decreased when
the collagen membrane was coated with chitosan. The corresponding pore size was between 20 and
70 µm, as determined by SEM (Figure 2, yellow arrows). Interaction between collagen and chitosan
was reported on hybrid scaffolds, demonstrating that a collagen-chitosan blend allowed for scaffold
formation with optimal surface homogeneity in terms of pore size and distribution [47]. In another
study, SEM analyses of collagen-chitosan scaffolds showed that the pores of the scaffolds were well
interconnected, with a mean diameter of 75–150 µm [48]. Because the CollaTape collagen sponge was
highly porous [28], the chitosan solution we used may penetrate deep into this 3-D structure. For this,
we performed additional SEM analyses on cross-sections of chitosan-coated and non-coated collagen
membranes. Data presented in Figure 2 showed that internal porosity of the collagen sponge still
present, with some of them still interconnected (Figure 2, yellow arrows). Thus, the chitosan coated
collagen membrane presents internal high porosity and pore interconnectivity. This suggests that
the chitosan was cross-linked to collagen at superficial level only. The presence of moderate surface
porosity in our chitosan coated collagen membrane may allow cell adhesion and penetration into the
matrix. After penetrating, the cells may have more space to proliferate invading all internal surface
of the scaffold. Thus, chitosan incorporation into the collagen sponge did not change the internal
structure of this sponge. These data are comparable to those already obtained with bacterial cellulose
functionalized with pectin [49] or aminoalkyl groups [50] or RGDC-gentamicin [51] showing reduced
pore density but still interconnected [48]. The SEM analyses showing chitosan presence onto the
collagen sponge was supported by XPS analyses. As shown in Figure 3, different bands representing
carbon, nitrogen, and oxygen that characterized the chitosan and collagen polymers were identified.
Indeed, the multiple bands we detected with the membranes confirmed the diverse possible linkages
between chitosan and collagen polymers. Figure 3 shows the C1S, O1S and N1S peaks of the various
XPS spectra generated by the chitosan-coated and non-coated collagen membranes. The C1S shows
three beads: at 284.7 eV, related to C–C, at 286.1 eV, related to C–N/C–O, and at 287.87 eV, related
to C=O/C–O–C. The N1S peak consists of two beads: a main one at 399.3 eV related to NH, a
non-protonated amine, and a second one at 401.3 eV, which is typical to NH+, a protonated amine.
The main O1S contribution is located at 532.7 eV, related to H–O–C, with a smaller contribution
at 531.12 eV. Figure 3 showed that the proportion of C–C groups relatively decreased when the
chitosan content increased from 0.1% to 1%, while the C–N/C–O groups increased due to the reaction
between the carbon from the collagen and the NH2 from the chitosan. The proportion of C–O and
N–H increased because of the composition of the chitosan. These results are in accordance with the
Zhu et al. study showing that cross-linking collagen to chitosan lead to an increased carbon content of
the collagen due to the introduction of chitosan in the matrix, whereas the nitrogen content decreased
in the crosslinked collagen/chitosan [52].
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membrane, extensively washed (W); (b) 0.1% chitosan‐coated collagen membrane, extensively W and 
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collagen  membrane,  non‐W;  (g)  1%  chitosan‐coated  collagen  membrane,  extensively  W;  (h)  1% 
chitosan‐coated collagen membrane, crosslinked with G and W; and  (i) 1% chitosan‐coated collagen 
membrane, crosslinked with G and non‐W. 
Figure 1. Protein comp siti n of chitosan-coate collagen me branes. Following chitosan-coated
collagen designed under various conditions, the produced membranes were subjected to Fourier
transform infrared (FTIR) analyses. Spectra were obtained and plotted: (a) Unmodified collagen
membrane, extensively washed (W); (b) 0.1% chitosan-coated collagen membrane, extensively
W and non-crosslinked; (c) 1% chitosan-coated collagen membrane, non-W and non-crosslinked;
(d) 0.1% chitosan-coated collagen membrane, crosslinked with glutaraldehyde (G) vapor and
W; ( ) 0.1% chitosan-coated collagen membrane, crosslinke with G vapor and non-W;
(f) 1% chitosan-coated collagen membrane, non-W; (g) 1% chitosan-coated collagen membrane,
extensively W; (h) 1% chitosan-coated collagen membrane, crosslinked with G and W; and (i) 1%
chitosan-coated collagen membrane, crosslinked with G and non-W.
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that  the prop rtio  of C–C groups relatively d creased when  the chitosa  c nt nt  incr ased  from 
0.1% to 1%, while the C–N/C–O groups increased due to the reaction between the carbon from the 
collagen and the NH2 from the chitosan. The proportion of C–O and N–H increased because of the 
composition of the chitosan. These results are in accordance with the Zhu et al. study showing that 
cross‐linking  collagen  to  chitosan  lead  to  an  increased  carbon  content of  the  collagen due  to  the 
introduction of chitosan  in  the matrix, whereas  the nitrogen content decreased  in  the crosslinked 
collagen/chitosan [52]. 
 
Figure  2.  Scanning  electron microscopy  (SEM)  analyses  of  chitosan‐coated  collagen membranes. 
Following  material  synthesis,  chitosan‐coated  and  non‐coated  membranes  crosslinked  with 
glutaraldehyde  vapor  were  processed  and  analyzed  under  SEM.  Structural  analyses  were 
performed on the surface of the membrane, and on the cross‐sections (n = 4). 
 
Figure 3. X‐ray photoelectron  spectroscopy  (XPS)  spectra of chitosan‐coated  collagen membranes. 
Materials with or without chitosan at various concentrations were synthesized and subjected to XPS 
analyses. Chemical composition spectra of the chitosan‐coated and non‐coated collagen membranes 
were compared (n = 4). 
Figure 2. Scanning electron microscopy (SE ) l ses of chitosan-coated collagen membranes.
Following material synthe is, chitosan-coat d non-coated membranes crosslinked with
glutaraldehyde vapor ere processed and analyzed under SEM. Structural analyses were performed
on the surface of the membrane, and on the cross-sections (n = 4).
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analyses. Chemical composition spectra of the chitosan-coated and non-coated collagen membranes
were compared (n = 4).
Because crosslinking chitosan-coated collagen membranes could alter the material’s mechanical
properties, a tensile stress-strain characterization was performed. The corresponding curves
generated under dry conditions are presented in Figure 4, which shows that adding 0.1% chitosan
to collagen membranes improved their rigidity. Indeed, the Young’s modulus increased from 23 MPa
(neat collagen membranes) to 180 MPa in the presence of 0.1 wt % chitosan (more rigid than collagen)
on the surface of the collagen membranes as well as inside the membrane pores supporting what has
been reported previously [53]. In addition, we demonstrated that when exposed to glutaraldehyde
vapor, the modified membranes became much more rigid and their Young’s modulus increased to
375 MPa, due to the crosslinking effect of both chitosan and collagen. By increasing the concentration
of chitosan to 1 wt %, both the untreated and glutaraldehyde-treated membranes showed an
additional increase in rigidity due to the densified crosslinking network, with respective Young’s
moduli of 290 and 430 MPa. However, a further increase of chitosan concentration led to
non-stretchable membranes, which may be undesirable for cartilage regeneration purposes. On the
other hand, under wet condition, referring to the membrane incubation in humid atmosphere for
24 h before tensile stress-strain characterization, the membranes rigidity showed a significant
decrease compared to the dried membranes, as shown in Figure 5 for neat collagen membranes and
collagen membranes modified with 0.1 wt % chitosan. The Young’s modulus decreased from 23 to
2.5 MPa for neat membranes and from 180 to 6 MPa for those modified with 0.1 wt % chitosan.
The influence of collagen crosslinking didn’t improve the membrane rigidity under wet condition
(the Young’s modulus remained around 2 MPa) but those modified with 0.1 wt % chitosan showed
a Young’s modulus increase from 6 to 41 MPa, which is largely lower than that observed under
dry condition. Shi et al. observed the same behavior for collagen/chitosan-silicone membrane
scaffolds [54]. They explained that water molecules act as plasticizers to the hydrophilic scaffold.
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membrane?rigidity?under?wet?condition? (the?Young’s?modulus?remained?around?2?MPa)?but? those?
modified?with?0.1?wt?%?chitosan? showed?a?Young’s?modulus? increase? from?6? to?41?MPa,?which? is?
largely? lower? than? that? observed? under? dry? condition.? Shi? et? al.? observed? the? same? behavior? for?
collagen/chitosan?silicone? membrane? scaffolds? [54].? They? explained? that? water? molecules? act? as?
plasticizers?to?the?hydrophilic?scaffold.?
?
Figure? 4.? Stress?strain? characterization? of? chitosan?coated? and? non?coated? collagen? membranes?
crosslinked?with?glutaraldehyde? (GTA)?vapor.?Analyses?were?performed?on?dried?membranes? (n?=?4).?
Ch:?Chitosan.?
?
Figure? 5.? Stress?strain? characterization? of? chitosan?coated? and? non?coated? collagen? membranes?
crosslinked?with?glutaraldehyde?vapor.?Analyses?were?performed?on?humidified?(H)?membranes.?
Figure 4. Stress-strain characterization of chitosa -c ated and no -coated collagen membranes
crosslinked with glutaraldehyde (GTA) vapor. Analyses were performed on dried me ra es
(n = 4). Ch: Chitosan.
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Figure 5. Stress-strain character zation of chitosa - ated and no -coated collagen membranes
crosslinked with glutaraldehyde vapor. Analyses were performed on humidiﬁed (H) membranes.
In our opinion, membrane ﬂexibility under wet conditions could be an advantage when used for
cartilage regeneration.
Overall, the chemical characterizations and mechanical property analyses suggest that
chitosan-coated collagen membranes can be used for in vitro cell cultures. However, one more
question still to be answered prior investigating chondrocyte interaction with the designed
membranes. This question is about the potential membrane degradation in the culture medium. We
performed weight lost analyses at 48 and 96 h of the membranes’ incubation in culture medium
at 37 ˝C. As shown in Figure 6, none of the chitosan coated or non-coated collagen membranes
showed weight lost. Our results are in agreement with a previously reported study demonstrating
that the presence of chitosan in composite chitosan-collagen scaffold can improve the biostability
of the scaffolds. This was dependent on the chitosan level [55]. The data presented in (Figure 6)
demonstrated that at short incubation time, the membrane did not degrade, which may be a good
support for in vitro cell culture.
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Figure?6.?Weight?lost?of?chitosan?coated?collagen?membrane?following?incubation?with?cell?culture?
medium.? Following? the? design? of? the? different?membranes,? these?were?weighted? at? time? zero.??
They?were?then?immersed?in?culture?medium?and?maintained?at?37?°C?for?48?and?96?h.?At?the?end?of?
each?incubation?period,?membrane?were?washed?with?sterile?water?and?dried?for?4?days.?The?weight?
of?each?membrane?was?registered?and?compared?to?the?initial?one;?n?=?4.?(a)?Membrane?weights?at?48?h;?
(b)?Membrane?weights?at?96?h.?
For?this?purpose,?we?performed?a?set?of?experiments?to?investigate?cell?adhesion?onto/into?these?
different?membranes.?As? shown? in?Figure? 7,? the? chondrocytes? adhered? to? and? spread?well?over? the?
chitosan?coated? collagen?membranes? and? collagen?membranes? after? 24?h?of? culture.?Cell?density?
was,? however,? higher? in? the? 1%? chitosan?coated? collagen?membranes? than? in? the? neat? collagen?
membranes?and?0.1%?chitosan?coated?collagen?membranes.?This?supports? the? findings?of?Wang?et?al.?
(2015)?who? reported?greater?osteoblast?adhesion? to? chitosan?collagen?blend? films? [56].?Moreover,?
similar?effects?were?obtained?with?adipose? stem? cells? cultured?onto?poly(??caprolactone)?chitosan?
material?[57].?The?enhanced?adhesion?we?showed?may? lead?to?cell?growth.?As?shown? in?Figure?8,?
the? quantitative? data? on? chondrocyte? proliferation? (MTT)? confirm? the? cyto?compatibility? of?
glutaraldehyde?crosslinked?chitosan?coated?collagen?membranes.?Of? interest? is? the?high?metabolic?
activity?of? the?chondrocytes?seeded?on? the?chitosan?coated?collagen?membranes?compared? to? that?
observed? on? the?neat? collagen?membranes.?This? effect?was? observed? at?different? culture?periods??
(48?and?96?h).?In?addition,?the?greater?the?chitosan?level,?the?higher?the?metabolic?activity?(Figure?8).?
Due?to?the?pore?size?ranging?between?20?and?50??m?in?out?designed?membranes,?it?is?more? likely?
that?the?cells?adhered?and?grew?on?the?surface?of?each?chitosan?coated?membrane.?Although,?with?
50??m?pore?size,?chondrocytes?may?get?into,?adhere?and?proliferate?because?the?chondrocyte?size?is?
estimated?to?be?from?10?to?40??m.?To?confirm?the?effect?of?chitosan?coated?collagen?membrane?on?
cell? adhesion? and? metabolic? activity,? we? performed? a? cell? viability? assay? using? trypan? bleu?
exclusion.? As? presented? in? Figure? 9,? the? total? live? cells? obtained?with? chitosan?coated? collagen?
Figure 6. Weight lost of chitosan-coated collag brane following incubation with cell culture
medium. Following the design the differ nt me branes, these w r weighted at time zero. Th y
were then im ersed in culture medium and maintained at 37 ˝C for 48 and 96 h. At the end of each
incubation period, membrane were washed with sterile water and dried for 4 days. The weight of
each membrane was registered and compared to the initial one; n = 4. (a) Membrane weights at 48 h;
(b) Membrane weights at 96 h.
For this purpose, we performed a set of experiments to investigate cell adhesion onto/into these
different membranes. As shown in Figure 7, the chondrocytes adhered to and spread well over the
chitosan-coated collagen membranes and collagen membranes after 24 h of culture. Cell density was,
however, higher in the 1% chitosan-coated collagen membranes than in the neat collagen membranes
and 0.1% chitosan-coated collagen membranes. This supports the ﬁndings of Wang et al. (2015) who
reported greater osteoblast adhesion to chitosan-collagen blend ﬁlms [56]. Moreover, similar effects
were obtained with adipose stem cells cultured onto poly(ε-caprolactone)-chitosan material [57]. The
enhanced adh sion we showed may lead to cell growth. As shown i Figure 8, the quantitative data
on chondrocyte proliferation (MTT) conﬁrm the cyto-compatibility of glutaraldehyde-crosslinked
chitosan-coated collage membranes. Of interest is the high metabolic activity of the chondrocytes
seeded on the chitosan-coated collagen membranes co pared to that observed on the neat collagen
membranes. This effect was observed at different culture periods (48 and 96 h). In addition,
the greater the chitosan level, the higher the metabolic activity (Figure 8). Due to the pore size
ranging between 20 and 50 μm in out designed membranes, it is more likely that the cells adhered
and grew on the surface of each chitosan-coated membrane. Although, with 50 μm pore size,
chondrocytes may get into, adhere and proliferate because the chondrocyte size is estimated to be
from 10 to 40 μm. To conﬁrm the effect of chitosan coated collagen membrane on cell adhesion and
etabolic activity, we perfor ed a cell viability assay using trypan bleu exclusion. As presented
in Figure 9, the total live cells obtained with chitosan- oated collagen membranes were higher s
compared to the control (simple collagen membranes). Inde d, after 48 h culture, the number of
live cells obtained with neat collagen was about 106 while with chitosan-coated collagen membranes
we got over 5 ˆ 106 demonstrating that the chitosan-collagen membranes promoted chondrocyte
proliferation. The same effect was obtained after 96 h culture, with greater live cell numbers with the
chitosan-coated membrane as compared to collagen membranes (Figure 9). This study supports those
reporting beneﬁcial uses of collagen/chitosan scaffolds in the culture of endothelial cells, ﬁbroblasts,
mesenchymal stem cells, nerve cells, and chondrocytes [58–62].
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?
Figure?7.?Chondrocyte?adhesion?on?chitosan?coated?collagen?membranes.?Cells?were?seeded?and?cultured?
for?24?h.?The?cells?were? then?stained?with?Hoechst?dye,?observed?under?an?ultraviolet?epifluorescence?
microscope,? and? photographed.? Photographs? (200×?magnification)? are? representative? of? six? separate?
experiments.? (a)?Collagen?membrane? alone;? (b)? 0.1%? chitosan? coated? collagen?membrane;? (c)? 1%?
chitosan?coated?collagen?membrane.?
?
Figure? 8.? Effect? of? chitosan?coated? collagen? membranes? on? chondrocyte? growth? and? metabolic?
activity.?Following?material?synthesis,?chondrocytes?were?seeded?onto?this?material?and?cultured?for?
various?time?periods.?Cell?growth?was?assessed?by?3?(4,5?dimethylthiazole?2?yl)?2,5?diphenyltetrazolium?
bromide?(MTT);?with?results?presented?as?means?±?standard?deviation?(SD)?(n?=?5).?A?difference?was?
considered?statistically?significant?at?p?<?0.05.?
Figure 7. Chondrocyte adhesion on chitosan-coated collagen membranes. Cells were seeded and
cultured for 24 h. The cells wer then stained with Hoechst dye, observed under an ultraviolet
epiﬂuorescence microscope, and photographed. Photographs (200ˆmagniﬁcation) are representative
of six separate experiments. (a) Collagen membrane alone; (b) 0.1% chitosan coated collagen
membrane; (c) 1% chitosan-coated collagen membrane.
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Figure 8. Effect of chitosan-coated collagen membranes on chondrocyte growth and metabolic activity.
Following material synthe is, chondrocytes were seeded onto this material a d cultured for various
time periods. Cell growth was assessed by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium
bromide (MTT); with results presented as means ˘ standard deviation (SD) (n = 5). A difference
was considered statistically signiﬁcant at p < 0.05.
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Figure? 9.? Level? of? live? chondrocytes? following? growth? on? chitosan?coated? collagen?membranes.?
Chondrocytes?were?seeded?onto?the?membranes?and?culture?for?48?and?96?h.?At?the?end?of?each?culture?
period,?cells?were?detached?and?the?live?cells?were?determined?using?trypan?bleu?exclusion?assay;?n?=?3.?
Because?chondrocytes?adhere?better?and?proliferate?when?cultured?on?chitosan?coated?collagen?
membranes,? this?may? lead? to? the?secretion?of?different?mediators? [63,64]? including? IL?6.? IL?6?was?
reported? to? be? secreted? by? chondrocytes? contributing? to? the?homeostasis? of? the? cartilage? and? its??
self?repair? by? promoting? chondrogenic? differentiation? [65].? For? this? purpose,?we?measured? IL?6?
levels? in?the?culture?supernatants?of?chondrocytes?cultured?on?the?different?membranes.?Our?data??
(Figure? 10)? showed? high? levels? of? IL?6? obtained?with? cells? cultured? on? chitosan?coated? collagen?
membranes?as?compared?to?those?cultured?on?neat?collagen?membranes.?This?not?only?confirms?the?
non?toxic?effect?of?glutaraldehyde?crosslinking?of?chitosan?to?collagen?on?cell?growth?and?cytokine?
synthesis?but? is?also? in?agreement?with?previous? results? [66]? showing?greater? cell?mineralization?
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Figure 9. Level of live chondrocytes following growth on chitosan-coated collagen membranes.
Chondrocytes were eed onto the membran s and cult re for 48 and 96 h. At the end of each
culture period, cells were detached and the live cells were determined using trypan bleu exclusion
assay; n = 3.
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Because chondrocytes adhere better and proliferate when cultured on chitosan-coated collagen
membranes, this may lead to the secretion of different mediators [63,64] including IL-6. IL-6 was
reported to be secreted by chondrocytes contributing to the homeostasis of the cartilage and its
self-repair by promoting chondrogenic differentiation [65]. For this purpose, we measured IL-6
levels in the culture supernatants of chondrocytes cultured on the different membranes. Our data
(Figure 10) showed high levels of IL-6 obtained with cells cultured on chitosan-coated collagen
membranes as compared to those cultured on neat collagen membranes. This not only conﬁrms the
non-toxic effect of glutaraldehyde crosslinking of chitosan to collagen on cell growth and cytokine
synthesis but is also in agreement with previous results [66] showing greater cell mineralization
when stem cells were cultured on chitosan-coated plates. Chitosan was also reported to upregulate
genes associated with calcium binding and mineralization, such as collagen type 1, integrin-binding
sialoprotein, osteopontin, osteonectin and osteocalcin [66]. Under physiological conditions, IL-6 is
also considered to be actively involved in cell-cell and cell-environment communication, therefore
participating in the cytokine network that involves other cytokines such as IL-1, tumor necrosis
factor (TNF), and epidermal growth factor (EGF) [67,68]. Cell growth and proliferation, and
cytokine secretion conﬁrmed the usefulness of the chitosan-coated collagen membrane. Due to its
biocompatibility and mechanical properties, the chitosan-coated collagen membrane we designed
may be added to those scaffolds already available for cartilage regeneration [69,70]. They may thus
offer additional alternative to different tissue engineering initiatives including cartilage.
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Because?chondrocytes?adhere?bet r?and?proliferate?when?cultured?on?chit san?coated?collage ?
membranes,? this?may? lead? to? the?secretion?of?differe t?mediators? [63,64]? including? IL?6.? IL?6?was?
reported? to? be? secreted? by? chondrocytes? contributing? to? the?homeostasis? of? the? cartilage? and? its??
self?repair? by? promoting? chondrogenic? differentiation? [65].? For? this? purpose,?we?measured? IL?6?
levels? in?the?culture?supernatants?of?chondrocytes?cultured?on?the?different?membranes.?Our?data??
(Figure? 10)? showed? high? levels? of? IL?6? obtained?with? cells? cultured? on? chitosan?coated? collagen?
membranes?as?compared?to?those?cultured?on?neat?collagen?membranes.?This?not?only?confirms?the?
non?toxic?effect?of?glutaraldehyde?crosslinking?of?chitosan?to?collagen?on?cell?growth?and?cytokine?
synthesis?but? is?also? in?agreement?with?previous? results? [66]? showing?greater? cell?mineralization?
when?stem?cells?were?cultured?on?chitosan?coated?plates.?Chitosan?was?also?reported?to?upregulate?
genes?ass ciated?with?calcium?binding?and?miner ization,?such?as?collagen?type?1,?integrin?bi ding?
sialoprot in,? steopontin,?osteonectin?and?osteocalci ? [66].?Under?physiological?cond tions,? IL?6? is?
also?considered?to?be?actively?involved?in?cell?cell?and?cell?environment?communication,?therefore?
participating? in? the? cytokine?network? that? involves?other? cytokines? such? as? IL?1,? tumor?necrosis?
factor? (TNF),? and? epidermal? growth? factor? (EGF)? [67,68].? Cell? growth? and? proliferation,? and?
cytokine?secretion?confirmed? the?usefulness?of? the?chitosan?coated?collagen?membrane.?Due? to? its?
biocompatibility?and?mechanical?properties,? the?chitosan?coated?collagen?membrane?we?designed?
may?be?added?to?those?scaffolds?already?available?for?cartilage?regeneration?[69,70].?They?may?thus?
offer?additional?alternative?to?different?tissue?engineering?initiatives?including?cartilage.?
?
Figure?10.?Effect?of?chitosan?coated?collagen?membranes?on?chondrocyte?IL?6?secretion.?Cells?were?
cultured?on?membranes?for?various?time?periods.?The?supernatants?were?collected?to?quantitate?IL?6?
levels? by? sandwich? enzyme?linked? immunosorbent? assay.? Values? are?means? ±? SD? (n? =? 4).? The?
difference?was?considered?statistically?significant?at?p?<?0.05.?
Figure 10. Effect of chitosan-coated collagen membranes on chondrocyte IL-6 secretion. Cells were
cultured on membranes for various time periods. The supernatants were collected to quantitate
IL-6 levels by sandwich enzyme-linked immunosorbent assay. Values are means ˘ SD (n = 4). The
difference was considered statistically signiﬁcant at p < 0.05.
5. Conclusions
Using a chitosan-coated collagen membrane designed in our laboratory, we performed chemical
analyses that conﬁrmed the presence of chitosan on the collagen membrane surface. This natural
polymer hybrid membrane promoted chondrocyte adhesion, proliferation, and IL-6 secretion.
Overall, this study demonstrates the potential contribution of a chitosan-coated collagen membrane
for use in cartilage regeneration strategies. In addition to the already available scaffolds for cartilage
regeneration, our designed chitosan-coated collagen membrane could be a good support for in vitro
chondrocytes growth then their implementation for clinical applications.
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